News

CW Bancorp Achieves Growth with $13.1M Earnings in 2024

CW Bancorp Achieves Growth with $13.1M Earnings in 2024

CW Bancorp Announces Strong Financial Performance for 2024

CW Bancorp (OTCQX: CWBK) has reported an impressive consolidated net income of $3.94 million or $1.30 per diluted share for the fourth quarter of 2024. This reflects a 16% increase in earnings per share (EPS) compared to the $1.13 per diluted share reported in the same quarter of the previous year. The total net income for the fiscal year ending in December 2024 was recorded at $13.1 million, translating to an EPS of $4.30, despite experiencing a 20% decrease compared to the $5.39 recorded for the twelve months ending December 2023.

Quarterly Financial Highlights

For the Three Months Ended December 31, 2024

  • EPS of $1.30, up 16%
  • Net income reached $3.94 million, an increase of 11%
  • Return on Assets (ROA) of 1.31%
  • Return on Tangible Equity (ROTE) of 18.95%
  • Loan growth quarter over quarter of 5.46%
  • Deposits rose 31% from the prior quarter
  • No outstanding Federal Reserve or Federal Home Loan Bank borrowings

Annual Financial Summary

For the Twelve Months Ended December 31, 2024

  • EPS was $4.30
  • Net income of $13.1 million
  • ROA recorded at 1.19%
  • ROTE reached 16.69%
  • Loan growth totaled $68.6 million, representing 9.5%
  • Deposits saw an increase of $183.9 million or 16%
  • Total assets expanded by $188.6 million or 14.5%

CEO's Insights on Performance

Mr. Ivo A. Tjan, the Chairman and CEO of CW Bancorp, expressed pride in the bank's achievements throughout 2024. He stated, "Our strong performance underlines the effectiveness of our client-focused approach. With notable loan and deposit growth, we continually affirm the power of customized financial solutions tailored specifically for small and medium-sized enterprises. As we step into 2025, our outlook remains cautiously optimistic in the face of ongoing economic challenges, including inflation. Our adaptability and innovative strategies will pave the way for future success, supported by our dedicated team who strive for excellence every day."

Highlights of Financial Growth

This year marked a significant increase in the bank's assets, which rose by $188.6 million from the previous year. Loans saw a $68.6 million increase, corresponding to a 9.5% rise as of December 31, 2024. Moreover, cash assets grew by 30%, contributing to the bank's solid financial standing.

Interest Income and Expense Growth

For Q4 2024, CW Bancorp reported interest income of $14,750,000, a 14% increase from $12,964,000 in Q4 2023. Interest expenses also rose, totaling $3,714,000 compared to $3,167,000 a year earlier, marking an increase of 17%.

Yearly interest income reached $54,190,000 in 2024, up from $52,185,000 in 2023. In contrast, total interest expenses for 2024 climbed to $14,241,000 from $11,468,000, illustrating a notable expense increase of 24%.

Future Prospects for CW Bancorp

Despite the challenges presented by fluctuating economic conditions, CW Bancorp is determined to redefine banking for small and medium businesses. The bank is committed to delivering tailored products and services through a customer-oriented approach, aiming to enhance the overall banking experience. With a mission to support businesses, CW Bancorp continues to improve the accessibility and range of its commercial banking services.

Frequently Asked Questions

What were the financial results for CW Bancorp in 2024?

The bank reported a net income of $13.1 million, with an EPS of $4.30 and a ROA of 1.19% for the fiscal year.

How did the fourth quarter compare to the previous year's fourth quarter?

The fourth quarter showed a net income of $3.94 million, surpassing the $3.54 million reported the previous year, reflecting an 11% increase.

What is the outlook for CW Bancorp as it enters 2025?

Management remains cautiously optimistic despite ongoing economic challenges, focusing on adaptability and innovation for future success.

How much did CW Bancorp's loans and deposits grow in 2024?

Loans grew by $68.6 million (9.5%), while deposits increased by $183.9 million (16%) throughout the year.

What strategies does CW Bancorp employ to support small businesses?

They focus on providing customized financial solutions tailored to the unique needs of small and medium-sized enterprises.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Micro Irrigation Systems: The Future of Sustainable Farming

Updated Category News Views 184

Micro Irrigation Systems: Transforming Global Agriculture The micro irrigation systems market is poised for remarkable growth, expected to expand significantly due to the increasing demand for sustainable agricultural practices. These systems are projected to elevate market valuation from USD 10.9 billion to USD 27.4 billion over the next decade, exhibiting a strong CAGR...

Continue Reading
Empowering Communities: Diaspora Groceries Supplier Summit Launch

Updated Category News Views 276

Empowering Communities: Diaspora Groceries Supplier Summit Launch Diaspora Groceries is thrilled to announce its inaugural Diaspora Diversity Supplier Summit, in partnership with its newly established nonprofit arm, Diaspora Groceries Cares. Taking place over two transformative days, the summit invites food suppliers, farmers, and advocates to gather for insightful...

Continue Reading
EMP Metals Unveils Enhanced Resource Estimate for Lithium Projects

Updated Category News Views 95

EMP Metals Reports Updated Resource Estimate EMP Metals Corp. (CSE: EMPS, OTCQB: EMPPF) is thrilled to share an updated Technical Report detailing the resource estimates for its Viewfield and Mansur lithium brine projects. This comprehensive report showcases a remarkable increase in the total resource, significantly boosting both the indicated and inferred lithium...

Continue Reading
Exploring the Impact of Google Cloud in Enterprise Solutions

Updated Category News Views 264

ISG Evaluates Google Cloud Partner Ecosystem Information Services Group (ISG) (Nasdaq: III), a prominent global technology research and advisory firm, is embarking on an in-depth research study that will gauge the effectiveness of service providers in supporting enterprises using the Google Cloud Platform (GCP) for artificial intelligence (AI) and various other workloads....

Continue Reading
HiRO Joins Forces with CHA University for Future of Health

Updated Category News Views 294

HiRO Collaborates with CHA University Bundang Medical Center Harvest Integrated Research Organization (HiRO), a distinguished global clinical research organization (CRO), has recently entered into a strategic partnership with CHA University Bundang Medical Center (CBMC), a highly respected medical institution in South Korea. This collaboration promises to strengthen the...

Continue Reading